TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

Benzinga Logo Benzinga By Vandana Singh
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

The FDA approved Novo Nordisk's Wegovy pill, the first oral GLP-1 weight-loss medication, which demonstrated 16.6% mean weight loss in trials. As GLP-1 adoption accelerates, major food and restaurant companies are rapidly adjusting their menus and products toward higher-protein, smaller-portion offerings to cater to changing consumer eating habits, with companies like ConAgra, Chipotle, and Danone already seeing strong performance in these new product lines.

Insights
GSpC   neutral

Mentioned as a joint book-running manager for the offering, performing a standard financial service role


NVO   positive

FDA approval of Wegovy pill as first oral GLP-1 therapy with strong clinical trial results (16.6% mean weight loss) and expected U.S. launch in early January 2026 represents significant market expansion opportunity.